Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-003334

Chief Legal Officer sold 573 shares at $1.76 ($1,008)

From the SEC's structured data for this filing

Trades in this filing

Miller Mary · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-07-21 Sale : show line 1 in the form −573 $1.76 $1,008 82,194 D
Open-market sales · 573 sh · avg $1.76 · $1,008
Loading xslF345X06/form4.xml…